The study was funded by the European Lymphoma Institute and other research groups. The researchers reported having no financial disclosures.
SOURCE: Federico M et al. Lancet Haematol. 2018 Jul 4. doi: 10.1016/S2352-3026(18)30090-5.
From the Journals
Rituximab reduces risk of follicular lymphoma transformation
Publish date: July 25, 2018
FROM THE LANCET HAEMATOLOGY